购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-59(Compound 177)是一种针对羟基类固醇17β-脱氢酶13(HSD17B13)的抑制剂,展示出优异的抑制活性,其IC50值≤ 0.1 μM。此化合物主要应用于研究肝病、代谢性疾病和心血管疾病,如NAFLD、NASH或药物性肝损伤(DILI)。
HSD17B13-IN-59(Compound 177)是一种针对羟基类固醇17β-脱氢酶13(HSD17B13)的抑制剂,展示出优异的抑制活性,其IC50值≤ 0.1 μM。此化合物主要应用于研究肝病、代谢性疾病和心血管疾病,如NAFLD、NASH或药物性肝损伤(DILI)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-59 (Compound 177), a potent inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13), exhibits an IC 50 value of ≤ 0.1 μM for estradiol. This compound is applicable in research related to liver, metabolic, and cardiovascular diseases, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and drug-induced liver injury (DILI) [1]. |
分子量 | 494.33 |
分子式 | C24H17Cl2N5O3 |
CAS No. | 2770247-11-3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.